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Abstract: Streptococcus gordonii, a member of the human indigenous oral microflora, colonizes smooth tooth surfaces and 
contributes to dental plaque formation. Although it is not recognized as being a cariogenic pathogen, it may cause endocarditis 
following invasion of the bloodstream. Using allelic exchange mutagenesis, we have constructed a mutant of S. gordonii (Challis) 
which is defective in its single functional glucosyltransferase gene and, hence, is unable to synthesize glucan exopolymers from 
sucrose. When examined in a rat endocarditis model, the sucrose-grown mutant did not differ significantly from S. gordonii 
wild-type, suggesting that glucan polymers did not contribute to infectivity. This result was in striking contrast to that previously 
observed with a polymer-defective S. mutans mutant. 
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Introduction 
Streptococcus gordonii (formerly Streptococcus 
sanguis [1]) is a normal inhabitant of the human 
oropharyngeal mucosa and smooth tooth sur- 
faces. In this environment it is considered indige- 
nous and relatively avirulent. However, this or- 
ganism may escape the oral cavity following rou- 
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tine dental or specialized procedures and enter 
the bloodstream [2,3]. The resulting bacteremia 
may cause infective endocarditis if underlying 
cardiac valvular disease exists in the host. Viri- 
dans streptococci including S. mutans and S. 
gordonii produce several extracellular enzymes 
which use sucrose to synthesize exopolymers. 
Glucosyltransferase (GTF) enzymes use the glu- 
cosyl moiety of sucrose to synthesize water-solu- 
ble or insoluble glucans. Fructosyltransferase 
(FTF) enzymes use the fructosyl moiety of su- 
crose to synthesize water soluble fructans. Based 
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on both biochemical and genetic analysis of a 
limited number of isolates, S. mutans strains usu- 
ally possess multiple GTF enzymes and a single 
FTF enzyme while S. gordonii appears to possess 
a single GTF enzyme [4-8]. Sucrose-derived poly- 
mers of S. mutans have been established as viru- 
lence factors in dental caries. Water-insoluble 
polymers are believed to facilitate tenacious ad- 
herence to the smooth tooth surface while the 
soluble polymers may contribute to virulence by 
acting as extracellular storage compounds, thus 
promoting long term organism survival [9-13]. 
Current evidence regarding pathogenesis of 
bacterial endocarditis suggests that a crucial step 
in the development of infection is the initial 
adherence of bacteria to endocardium. Morpho- 
logical studies with experimental models of endo- 
carditis have demonstrated that the initial colo- 
nization occurs in areas of endocardial trauma on 
fibrin-platelet deposits [14-17]. Synthesis of glu- 
can polymer has been correlated with the ability 
of S. sanguis to adhere to damaged heart valve 
leaflets in vitro [18,19] and has been associated 
with increased infectivity in vivo [18]. Dextranase 
treated cells showed decreased adherence to fib- 
rin-platelet matrix in vitro and decreased rate of 
infection in the animal model of endocarditis 
[18,191. 
Recently, Munro and Macrina [20] have used a 
defined mutant of S. mutans to evaluate the 
contribution of sucrose-derived polymer forma- 
tion to infectivity in a rat endocarditis model. 
This mutant, unable to synthesize either glucans 
or fructans from sucrose, was constructed by al- 
lelic exchange. Sucrose-grown cells were signifi- 
cantly less virulent than similarly-grown or glu- 
cose-grown wild-type cells. Using similar allelic 
exchange mutagenesis techniques, we have con- 
structed a glucosyltransferase-deficient mutant of 
S. gordonii. As expected, this mutant was devoid 
of glucan polymer biosynthetic capability. When 
examined in a rat model for endocarditis, su- 
crose-grown mutant cells did not differ signifi- 
cantly from S. gordonii wild-type cells, suggesting 
that glucan polymers were not contributing to 
infectivity. This is in striking contrast to results 
seen with the polymer-defective S. mutans mu- 
tant. 
Materials and Methods 
Bacterial strains and media 
The strain of Streptococcus gordonii used in 
this work, CH1, is a Challis strain which exhibits 
a characteristic hard colony phenotype desig- 
nated Spp + (sucrose promoted phenotype posi- 
tive; [4]) when grown on Todd Hewett media 
(Difco Labs, Detroit, MI) containing 3% sucrose. 
For use in the endocarditis experiments, the 
strains were grown overnight in Todd Hewett 
broth (Difco Laboratories) anaerobically at 37°C. 
Fresh Todd Hewett broth containing 3% sucrose 
was inoculated with 0.5 ml of the overnight cul- 
ture and allowed to grow to late log phase prior 
to use as animal inocula. GTF assays were per- 
formed using broth culture supernatants of brain 
heart infusion (Difco Laboratories) grown cells. 
Transformation of S. gordonii was accomplished 
as previously described [21]. 
Mutagenesis 
The S. gordonii mutant AMS12 was con- 
structed by allelic exchange in order to inactivate 
the GTF gene, gtfG (see Fig. 1). Disruption of 
the gtfG gene in strain AMS12 was verified by 
Southern blot analysis using four different DNA 
hybridization probes: pTV32(Ts), and the 4-, 1.5-, 
and 3.3-kb HindIII fragments which contained 
portions of the gtfG gene (see Fig. 1). The XbaI 
3.2-kb chromosomal component identified in the 
wild type strain was missing in strain AMS12 and 
was replaced by a 6.4-kb fragment (see XbaI sites 
in Fig. 1). This fragment is larger than the 3.2-kb 
fragment by the difference in size (approx. 3.2 kb) 
between the lacZ-erm DNA cassette (4.7 kb) and 
the 1.5-kb HindIII fragment. Thus, this analysis 
confirmed the replacement of the 1.5-kb frag- 
ment of the gtfG gene by the lacZ-erm cassette 
as illustrated in Fig. 1. 
Assay of glucosyltransferase activity 
The production of extracellular GTF in culture 
supernatants of both CH1 and AMS12 was as- 
sayed using acetone precipitates of brain heart 
infusion-grown cells cultivated at 37°C to late log 
phase. Glucan assays monitored 14C-glucose in- 
corporation into methanol-insoluble material us- 
ing radioisotopic sucrose as a substrate [10]. 
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Fig. 1. Construction of the gtfG mutant of S. gordonii. The 
gtfG gene spans three HindlII fragments as indicated by the 
top line labelled 'S. gordonii CH1 chromosome' in Fig. 1 [5]. 
The 5' end of the chromosomal gtfG gene begins within a 
4-kb HindllI fragment, extends through a 1.5-kb HindlII 
fragment (open rectangle), and terminates within a 3.3-kb 
HindllI fragment as indicated by the arrow. The two flanking 
HindllI fragments were isolated and ligated to the lacZ-erm 
cassette as seen in Fig. 1 (second line marked 'Ligated DNA 
fragments'). They are: i) a 4.7-kb lacZ-erm DNA cassette 
containing KpnI and BamHI cohesive ends isolated from 
pTV32(Ts) [26]; ii) the 4-kb HindlII fragment flanked by 
DNA containing ClaI and BamHI cohesive ends; and, iii) a 
2.5-kb fragment containing SphI and Kpnl cohesive ends. 
The ligated fragments were introduced into S. gordonii CH1 
by transformation. Erythromycin-resistant colonies were ob- 
tained, one of which was designated strain AMS12. Two 
reciprocal recombination events, between the target cell's 
chromosome and DNA flanking the lacZ-erm determinants, 
resulted in the replacement of the 1.5-kb chromosomal 
HindlII fragment with the lacZ-erm DNA giving rise to the 
structure seen at the bottom of Fig. 1 ('S. gordonii AMS12 
chromosome'). 
Endocarditis testing 
The technique used to produce endocarditis in 
male Sprague-Dawley rats was adapted from San- 
toro and Levison [22] and our use of it has been 
previously described [20]. 
Results 
Construction and analysis of glucosyltransferase 
defective mutant 
A glucosyltransferase-deficient mutant of S. 
sanguis CH1 was prepared by allelic exchange as 
described in Materials and Methods and illus- 
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trated in Fig. 1. This mutant displayed a stable 
erythromycin resistance phenotype as expected 
from the loss of an internal segment of the gtfG 
gene with a concomitant insertion of a drug resis- 
tance cassette. Extracellular protein preparations 
of the wild-type CH1 and AMS12 mutant strains 
were prepared and assayed for GTF activity as 
measured by incorporation of 14C-glucose (from 
14C-glucose-labeled sucrose) into methanol insol- 
uble material. Activities were standardized by 
expressing incorporated cpm per microgram of 
protein in the assayed material. The wild type 
strain displayed activity defined in this manner at 
a level of 218 + 41 (total of 9 repititions using 2 
independently-prepared protein extracts). Similar 
analysis using extracellular protein preparations 
from the AMS12 mutant strains failed to reveal 
GTF activity. Enzyme levels could not be distin- 
guished from negative control baseline (3.8 + 7.7). 
These results corroborated the predicted geno- 
type of the mutant and confirmed the presence of 
a single active GTF gene in the wild type CH1 
strain. A genetic switching mechanism which af- 
fects GTF activity in S. gordonii CH1 has been 
reported [4,5]. Switching involved differences in 
GTF levels that range from 4- to 10-fold, with 
low-level producing variants still displaying de- 
tectable GTF activity. This is in contrast to the 
gtfG mutant reported here. Enzyme activity is 
reduced approximately 60-fold in the AMS12 mu- 
tant, to a level which is statistically consistent 
with its absence. 
Virulence in the rat model of endocarditis 
The ability of the GTF deficient strain 
(AMS12) to cause endocarditis was compared 
with that of the wild-type (CH1) in the rat model. 
Seventy-two hours following injection of a 10 7 
inoculum of either the sucrose-grown wild-type 
(CH1) or the mutant (AMS12) cells the animals 
were sacrificed and their hearts removed and 
visually inspected for proper catheter placement 
across the aortic valve. In every case where 
catheter placement was correct, vegetations were 
observed. The number of animals that developed 
infective endocarditis as determined by positive 
vegetation cultures was similar in both the wild- 
type and mutant inoculated animals, 53.2% and 
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Table 1 
Endocarditis cases in rats inoculated with S. gordonii CH1 or 
AMS12 a 
Strain Cases b Total c Percent infected 
CH1 16 30 53.3 
AMS12 18 32 56.2 
a Animals were inoculated with 107 cells; b Number of ani- 
mals with streptococci recovered from vegetation; c Surviving 
animals with proper catheter placement at autopsy. 
56.2% respectively (Table 1). These data were 
analyzed using both the Test of Proportions and 
the Chi Square Test. Both statistical analyses 
indicated the differences between the CH1 and 
the AMS12 infection frequencies were not signifi- 
cant (P > 0.01 for the Test of Proportions and 
P > 0.05 for the Chi Square Test). Animals in 
both groups were inoculated either 24 or 48 h 
following catheterization. In order to determine if 
any difference existed within these groups, we 
compared the proportion of endocarditis cases 
among animals injected after 24 h to the propor- 
tion of endocarditis cases among those injected at 
48 h. No significant difference was found (data 
not shown). 
Discussion 
Streptococci of the viridans group, including S. 
gordonii, are the leading cause of native valve 
endocarditis accounting for 45-65% of cases 
[23,24]. Earlier reports have suggested that glucan 
formation by viridans streptococci may enhance 
adherence to the damaged cardiac valvular en- 
dothelium in vitro and have a greater etiological 
association with endocarditis in vivo as compared 
to strains of streptococci that do not produce 
glucan [18,19]. Our application of allelic exchange 
mutagenesis has allowed the direct comparision 
of the contribution of sucrose-derived polymers 
in endocarditis infectivity using S. gordonii iso- 
genic strains. Recently, Munro and Macrina [20] 
have reported that a non-polymer synthesizing, 
multiple mutant of S. mutans (devoid of all gluco- 
syltransferase and fructosyltransferase activity) is 
significantly less infective in the rat endocarditis 
model as compared to wild-type, sucrose grown 
cells. In their study, the mutant constructed in- 
volved the inactivation of all four polymer synthe- 
sizing determinants (three GTFs and a single 
fructosyltransferase gene). These results prompt- 
ed us to look in a similar manner at S. gordonii to 
evaluate specifically the role in virulence of su- 
crose-derived polymers in this species. Our rat 
endocarditis data clearly indicate no significant 
difference in virulence between the glucan nega- 
tive mutant and the glucan positive wild-type S. 
gordonii strain (Table 1). 
We conclude that generalizations about the 
role of sucrose-derived polymers in endocarditis 
infectivity are not possible as regards the viridans 
streptococci. Many of the oral viridans strepto- 
cocci are able to synthesize glucans and, in some 
cases, fructans from sucrose. Our results taken 
together with those of Munro and Macrina [20], 
indicate that exopolymers vary in their contribu- 
tion to endocarditis infectivity when comparing S. 
mutans and S. gordonii. Not surprisingly, this 
suggests a varied, multifactoral array of virulence 
factors are operative in mutans-initiated vs. gor- 
donii-initiated lesions. Furthermore, it is impor- 
tant to note that single strain, isogenic mutant 
comparisons must be viewed with caution due to 
the heterogeneity of the virdans streptococci in 
general [25]. It is possible that the examination of 
several independent isolates must be performed 
in order to gain a more generalized picture of the 
factors important to infectivity. It is also impor- 
tant to note the previous S. mutans analyses 
involved a mutant defective in 4 different en- 
zymes. It can be argued that the array of glucans 
and fructans made by wild-type S. mutans collec- 
tively contributes to infectivity in a way which is 
significantly different from the glucan produced 
by the single GTF of S. gordonii. The results 
reported here are important in that they provide 
new, comparative information, using a precisely- 
defined isogenic strain pair representing another 
oral species of Streptococcus. Data with S. mu- 
tans suggested that the sucrose-derived polymers 
contributed to endocarditis infectivity in two, 
non-mutually exclusive ways: promoting adher- 
ence to fibrin and interfering with phagocytic 
killing [20]. We infer from our infectivity studies 
with S. gordonii CH1 and its glucan-defective 
mutant that fibrin adherence mechanisms and 
anti-phagocytosis strategies important in endo- 
carditis are independent of sucrose-derwed exo- 
polymer formation in this strain. 
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